NGT HealthCare II

Venture Capital Nazareth, Israel Est. 2021
Visit website ↗ LinkedIn
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
—

About

NGT HealthCare II is an impact venture capital fund investing and growing startup companies in the fields of biotechnology, pharma, bio-convergence, and medical device. The former fund, NGTVC invested in 23 medical innovative companies. The second fund, NGT Healthcare II invested already in 22 promising companies. NGT holds a franchise from the Authority for innovation to operate technological incubator in Nazareth. Among NGT HealthCare II partners are the Tehnion, Hadasit, IBI, Falcon Group Capital, Jacobs Investment Company, GIG Limited, A3 Investment Group, Arkin Holdings, OurCrowd, Salvador Pascual Sanchez Gijon, Imad and Reem Younis. NGT HealthCare II management has the experience and expertise in supporting medical startups from identifying breakthrough technologies through R&D, clinical trials, fund raising, all the way to presenting a valuable product to the market. The Fund has a 1,300 square meter facility in Nazareth including laboratories and three clean rooms. NGT HealthCare II's impact vision is to propel healthcare and life-saving technologies, encourage Arab society and contribute to a stronger economy and an inclusive and equitable Israeli society.

Portfolio

No portfolio companies in this dataset yet.

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is NGT HealthCare II's primary investment focus?
NGT HealthCare II is an impact venture capital fund that invests in startup companies within biotechnology, pharma, bio-convergence, and medical device sectors.
How many companies has NGT HealthCare II invested in since its inception?
NGT HealthCare II has invested in 22 promising companies. Its predecessor fund, NGTVC, invested in 23 medical innovative companies.
What is the total amount of capital raised by NGT HealthCare II?
NGT HealthCare II raised $92 million, as reported in news from March and October 2022.
Can you name some notable portfolio companies of NGT HealthCare II?
Notable portfolio companies include Kailo Pharma, which received a $2.1 million investment in March 2026, and Nurami Medical, which received a $30 million investment in March 2025.
What is NGT HealthCare II's geographic base and operational setup?
NGT HealthCare II is headquartered in Nazareth, Israel, and operates a technological incubator with a 1,300 square meter facility, including laboratories and three clean rooms.
What is NGT HealthCare II's approach to leading investment rounds?
NGT HealthCare II frequently acts as a lead investor, for example, in Kailo Pharma's $2.1 million round in March 2026 and Orsight Pharma's $2.1 million round in January 2023.
What is NGT HealthCare II's impact vision?
NGT HealthCare II's impact vision is to propel healthcare and life-saving technologies, encourage Arab society, and contribute to a stronger economy and an inclusive and equitable Israeli society.
Who are some of the partners involved with NGT HealthCare II?
Partners of NGT HealthCare II include the Technion, Hadasit, IBI, Falcon Group Capital, Jacobs Investment Company, GIG Limited, A3 Investment Group, Arkin Holdings, OurCrowd, Salvador Pascual Sanchez Gijon, Imad and Reem Younis.